Table 3. Tissue velocity imaging parameters of the mitral annulus in the high-dose prednisolone group.
Tissue-doppler-mode | Median |
|||||
---|---|---|---|---|---|---|
Day 0 | Day 7 | Day 28 | Day 56 | Day 84 | ||
IVS velocity | ||||||
Sm (cm/sec) | 6.89 (4.34–8.44) | 6.51 (5.45–10.18) | 8.57* (5.25–10.46) | 9.06* (7.28–10.14) | 9.06* (7.52–10.27) | |
Em (cm/sec) | 6.12 (4.64–7.27) | 5.72 (3.27–7.42) | 5.15* (4.86–5.41) | 4.62** (3.77–5.65) | 4.92** (4.32–5.61) | |
Am (cm/sec) | 3.80 (2.97–5.99) | 3.76 (1.76–5.63) | 4.65 (3.65–6.42) | 4.75 (3.53–5.27) | 4.39 (2.71–5.99) | |
Em/Am | 1.46 (1.20–1.94) | 1.72 (0.91–2.58) | 1.11* (0.80–1.42) | 0.98 (0.76–1.31) | 1.17 (0.74–1.59) | |
E/Em | 6.37 (11.88–23.11) | 7.86 (12.22–27.22) | 10.88* (17.19–28.71) | 12.54** (20.77–31.39) | 10.92** (19.31–28.30) | |
LVFW velocity | ||||||
Sm (cm/sec) | 7.29 (4.93–10.43) | 9.13 (6.57–10.27) | 10.20* (8.27–10.54) | 10.07* (6.83–10.56) | 10.05 (5.89–10.52) | |
Em (cm/sec) | 5.65 (4.36–9.52) | 7.12 (4.05–9.15) | 7.15 (6.00–9.06) | 6.52 (3.23–8.24) | 5.08 (2.51–7.32) | |
Am (cm/sec) | 3.81 (2.87–7.48) | 4.70 (2.67–7.03) | 5.17 (4.53–7.36) | 4.75 (2.92–6.62) | 5.11 (3.3–7.15) | |
Em/Am | 1.40 (0.94–2.15) | 1.44 (1.30–2.06) | 1.39 (0.95–2.00) | 1.14 (0.87–2.74) | 0.92 (0.66–1.61) | |
E/Em | 4.60 (8.97–20.30) | 5.94 (10.65–23.87) | 6.00* (10.92–22.29) | 7.62** (14.26–38.70) | 11.45* (14.80–47.54) |
Am: peak velocities of left ventricular myocardium at late diastole; Day 0: Before initiation of medication; Day 7: 7 days after the initiation of medication; Day 28: 28 days after the initiation of medication; Day 56: 56 days after the initiation of medication; Day 84: 84 days after the initiation of medication; Em: peak velocities of left ventricular myocardium at early diastole; IVS: interventricular septal; LVFW, left ventricular free wall; Sm: peak velocities of left ventricular myocardium at systole. Data are expressed as medians (range). * and ** Indicate significant difference compared to Day 0 values at P<0.05 and P<0.01, respectively.